Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Uterine Cervical Neoplasms 81Endometrial Neoplasms 22Ovarian Neoplasms 12Vaginal Neoplasms 11Vulvar Neoplasms 10Neoplasms 8Sarcoma 6Carcinoma, Ovarian Epithelial 5Pelvic Neoplasms 4Fallopian Tube Neoplasms 4Wilms Tumor 3Urinary Bladder Neoplasms 3Testicular Neoplasms 3Prostatic Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Locally Advanced Cervical Cancer 3Endometrial Clear Cell Adenocarcinoma 3Dendritic Cell Sarcoma, Interdigitating 3Burkitt Lymphoma 3Breast Neoplasms 3Anus Neoplasms 3Uterine Neoplasms 2Teratoma 2Sezary Syndrome 2Sarcoma, Endometrial Stromal 2Recurrence 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pheochromocytoma 2Penile Neoplasms 2

Interventions

bintrafusp alfa protein, human 1Radiotherapy 1Paclitaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Camurati-Engelmann Syndrome × Radiotherapy × Gynecologic × Clear all
NCT04551950 2024-03-08

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

EMD Serono

Phase 1 Completed
25 enrolled 14 charts
Gynecologic

Uterine Cervical Neoplasms, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡